½ÃÀ庸°í¼­
»óǰÄÚµå
1619128

ÀçÅà ¼ö¾× ¿ä¹ý ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® : Á¦Ç°º°, ¿ëµµº°, Åõ¿©¹ýº°, Áö¿ªº° - »ê¾÷º° ¿¹Ãø(2024-2031³â)

Home Infusion Therapy Market Size, Share, Growth Analysis, By Product (Infusion Pumps, Intravenous Sets), By Application (Anti Infective, Endocrinology, Hydration Therapy), By Administration, By Region - Industry Forecast 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: SkyQuest | ÆäÀÌÁö Á¤º¸: ¿µ¹® 165 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÀçÅà ¼ö¾× ¿ä¹ý ½ÃÀå ±Ô¸ð´Â 2022³â¿¡ 354¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2023³â 385¾ï ´Þ·¯¿¡¼­ 2031³â¿¡´Â 718¾ï ´Þ·¯·Î ¼ºÀåÇϸç, ¿¹Ãø ±â°£ Áß(2024-2031³â) CAGRÀº 8.1%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

½ÃÀå ÀλçÀÌÆ®¿¡ µû¸£¸é ȯÀÚÀÇ ºñ¿ë Àý°¨°ú ÀçÅà ġ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϸ鼭 ƯÈ÷ ¼ö¾× ¿ä¹ý¿¡¼­ ÀçÅÃÄ¡·á·ÎÀÇ ÀüȯÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³ª°í ÀÖ½À´Ï´Ù. COVID-19·Î ÀÎÇØ º´¿øÀÇ ÀÚ¿øÀÌ ºÎÁ·ÇØÁö¸é¼­ ¸¹Àº ȯÀÚµéÀÌ ÇʼöÀûÀÎ ÀÇ·á ¼­ºñ½º¸¦ Áö¼ÓÇϱâ À§ÇØ ÀçÅà ġ·á¸¦ ¼±ÅÃÇß½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â ¼ö¾× ÀåºñÀÇ ±â¼ú ¹ßÀü°ú ȯÀÚ°¡ ´õ Æí¸®ÇÑ ¿É¼ÇÀ» ¿øÇÔ¿¡ µû¶ó ÀçÅà ġ·á¸¦ ¼±È£ÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¿É¼Ç Äɾî Çコ(Option Care Health Inc.)¿Í °°Àº ÀçÅà ¼ö¾× ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â º´¿ø ¹× ¾à±¹°ú Çù·ÂÇÏ¿© ȯÀÚÀÇ Ä¡·á Á¢±ÙÀ» °£¼ÒÈ­ÇÏ°í °³Àκ° ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÕ´Ï´Ù. ȯÀÚµéÀÇ Ä¡·á Á¢±ÙÀ» °£¼ÒÈ­ÇÏ°í °³Àκ° ¸ÂÃã Ä¡·á °èȹÀ» ¼ö¸³Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çù·ÂÀº ƯÈ÷ ½ÅÈï ±¹°¡ ½ÃÀå¿¡¼­ ÀçÅà ¼ö¾× °ø±Þ ¹× ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀçÅÃÄ¡·á ¼Ö·ç¼ÇÀÇ Àü¹ÝÀûÀÎ Àü¸ÁÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

¸ñÂ÷

¼­·Ð

  • Á¶»çÀÇ ¸ñÀû
  • Á¶»ç ¹üÀ§
  • Á¤ÀÇ

Á¶»ç ¹æ¹ý

  • Á¤º¸ Á¶´Þ
  • 2Â÷ µ¥ÀÌÅÍ¿Í 1Â÷ µ¥ÀÌÅÍ ¹æ¹ý
  • ½ÃÀå ±Ô¸ð ¿¹Ãø
  • ½ÃÀåÀÇ ÀüÁ¦Á¶°Ç°ú Á¦ÇÑ

°³¿ä

  • ¼¼°è ½ÃÀå Àü¸Á
  • °ø±Þ°ú ¼ö¿äÀÇ µ¿Ç⠺м®
  • ºÎ¹®º° ±âȸ ºÐ¼®

½ÃÀå ¿ªÇаú Àü¸Á

  • ½ÃÀå °³¿ä
  • ½ÃÀå ±Ô¸ð
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀΰú ±âȸ
    • ¾ïÁ¦¿äÀΰú °úÁ¦
  • PorterÀÇ »ê¾÷ ºÐ¼®°ú ¿µÇâ
    • °æÀï ±â¾÷ °£ °æÀï °ü°è
    • ´ëüǰÀÇ À§Çù
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â

ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®

  • ÁÖ¿ä ¼º°ø ¿äÀÎ
  • °æÀïÀÇ Á¤µµ
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ½ÃÀå ¿¡ÄڽýºÅÛ
  • ½ÃÀåÀÇ ¸Å·Â Áö¼ö(2023³â)
  • PESTEL ºÐ¼®
  • °Å½Ã°æÁ¦ ÁöÇ¥
  • ¹ë·ùüÀÎ ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±â¼úÀÇ Áøº¸
  • ±ÔÁ¦ »óȲ
  • »ç·Ê ¿¬±¸
  • ƯÇ㠺м®

ÀçÅà ¼ö¾× ¿ä¹ý ½ÃÀå ±Ô¸ð : Á¦Ç°º° & CAGR(2024-2031³â)

  • ½ÃÀå °³¿ä
  • ÁÖÀÔ ÆßÇÁ
    • ¿¤¶ó½ºÅä¸Ó
    • Àü±â ±â°è
    • Áß·Â
    • ±âŸ
  • Á¡Àû ¼¼Æ®
  • IV ij´¼¶ó
  • ´Ïµé¸®½º Ä¿³ØÅÍ

ÀçÅà ¼ö¾× ¿ä¹ý ½ÃÀå ±Ô¸ð : ¿ëµµº° & CAGR(2024-2031³â)

  • ½ÃÀå °³¿ä
  • Ç×°¨¿°
  • ³»ºÐºñÇÐ
    • ´ç´¢º´
    • ±âŸ
  • ¼öºÐ º¸±Þ ¿ä¹ý
    • ¿îµ¿¼±¼ö
    • ±âŸ
  • È­Çпä¹ý
  • °æÀ念¾ç
  • ºÎ¸ð ¿µ¾ç
  • Àü¹® ÀǾàǰ
  • ±âŸ

ÀçÅà ¼ö¾× ¿ä¹ý ½ÃÀå ±Ô¸ð : Åõ¿© °æ·Îº° & CAGR(2024-2031³â)

  • ½ÃÀå °³¿ä
  • ±ÙÀ°³»
  • ÇÇÇÏ ÁÖ»ç
  • °æ¸·¿Ü ¸¶Ãë

ÀçÅà ¼ö¾× ¿ä¹ý ½ÃÀå ±Ô¸ð & CAGR(2024-2031³â)

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ½ºÆäÀÎ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • GCC ±¹°¡
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

°æÀï Á¤º¸

  • »óÀ§ 5»çÀÇ ºñ±³
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2023³â)
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«
  • ½ÃÀåÀÇ ÃÖ±Ù µ¿Çâ
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • ÁÖ¿ä ±â¾÷ÀÇ ±â¾÷ °³¿ä
  • Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼®
  • ºÎ¹®º° Á¡À¯À² ºÐ¼®
  • ¸ÅÃâÀÇ Àü³â´ëºñ ºñ±³(2021-2023³â)

ÁÖ¿ä ±â¾÷ °³¿ä

  • Baxter International Inc.(¹Ì±¹)
  • Fresenius Kabi AG(µ¶ÀÏ)
  • Teva Pharmaceutical Industries Ltd.(À̽º¶ó¿¤)
  • McKesson Corporation(¹Ì±¹)
  • Option Care Health(¹Ì±¹)
  • AmerisourceBergen Corporation(¹Ì±¹)
  • CVS Health(¹Ì±¹)
  • Walgreens Boots Alliance(USA/UK)
  • Cardinal Health(¹Ì±¹)
  • Linde plc(¿µ±¹)
  • Centene Corporation(¹Ì±¹)
  • UnitedHealth Group(¹Ì±¹)
  • Anthem, Inc.(¹Ì±¹)
  • Humana Inc.(¹Ì±¹)
  • Cigna Corporation(¹Ì±¹)
  • Koninklijke Philips N.V.(³×´ú¶õµå)
  • Smiths Medical(¿µ±¹)
  • ICU Medical, Inc.(¹Ì±¹)
  • Terumo Corporation(ÀϺ»)
  • BD(¹Ì±¹)
  • °á·Ð & Ãßõ
KSA 25.01.15

Global Home Infusion Therapy Market size was valued at USD 35.4 billion in 2022 and is poised to grow from USD 38.5 billion in 2023 to USD 71.8 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031).

Market insights indicate a significant shift towards home healthcare, particularly in infusion therapies, driven by reduced patient costs and a surge in demand for home-based treatments. With hospitals experiencing resource strain due to the pandemic, many patients opted for home care to continue essential medical services. Key market drivers include technological advancements in infusion devices and a growing preference for home treatments, as patients seek more convenient options. Home infusion service providers, such as Option Care Health Inc., are partnering with hospitals and pharmacies to streamline patient access to care and tailor personalized treatment plans. This collaboration has fueled the demand for home infusion supplies and services, especially in developed markets, enhancing the overall landscape of home healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Home Infusion Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Home Infusion Therapy Market Segmental Analysis

Global Home Infusion Therapy Market is segmented by Product, Application, Administration and Region. Based on Product, the market is segmented into Infusion Pumps (Elastomeric, Electromechanical, Gravity, Others), Intravenous Sets, IV Cannulas, Needleless Connectors. Based on Application, the market is segmented into Anti Infective, Endocrinology (Diabetes, Others), Hydration Therapy (Athletes, Others), Chemotherapy, Enteral Nutrition, Parental Nutrition, Specialty Pharmaceuticals, Others. Based on Administration, the market is segmented into Intramuscular, Subcutaneously, Epidural. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Home Infusion Therapy Market

One of the primary factors fueling the growth of the global home infusion therapy market is the escalating incidence of chronic illnesses, including diabetes, cancer, and cardiovascular diseases. As more individuals require ongoing medical attention and treatment, home infusion therapy emerges as a convenient and effective solution. This method not only minimizes the need for hospital visits but also enhances patient comfort, making it an appealing option for both healthcare providers and patients. The demand for effective management of chronic conditions is expected to further boost the market, highlighting the importance of home infusion services in contemporary healthcare practices.

Restraints in the Global Home Infusion Therapy Market

One significant constraint hindering the expansion of the global home infusion therapy market is the insufficient awareness and training among both healthcare professionals and patients. Many patients lack a clear understanding of home infusion therapy, leading to underutilization of these services. On the other hand, healthcare providers often do not receive adequate training in managing infusion therapies or guiding patients through pre-treatment processes. This knowledge gap not only affects the quality of care provided but also limits patient acceptance and adoption of home infusion therapy, ultimately impacting the overall growth prospects and market share of this vital healthcare sector.

Market Trends of the Global Home Infusion Therapy Market

The global home infusion therapy market is witnessing a significant shift towards patient-centric care, reflecting a growing preference for personalized treatment plans that prioritize individual patient needs. This trend is driven by the increasing demand for convenience and comfort, allowing patients to manage chronic conditions from the comfort of their homes while reducing hospital visits and associated healthcare costs. advancements in infusion technologies, enhanced caregiver training, and improved patient education are further fueling this trend, making home infusion a viable alternative to traditional hospital-based care. As a result, the market is poised for robust growth, catering to a more empowered and involved patient population.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies
  • Patent Analysis

Home Infusion Therapy Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Infusion Pumps
    • Elastomeric
    • Electromechanical
    • Gravity
    • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

Home Infusion Therapy Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Anti Infective
  • Endocrinology
    • Diabetes
    • Others
  • Hydration Therapy
    • Athletes
    • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parental Nutrition
  • Specialty Pharmaceuticals
  • Others

Home Infusion Therapy Market Size by Administration & CAGR (2024-2031)

  • Market Overview
  • Intramuscular
  • Subcutaneously
  • Epidural

Home Infusion Therapy Market Size & CAGR (2024-2031)

  • North America (Product, Application, Administration)
    • US
    • Canada
  • Europe (Product, Application, Administration)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Product, Application, Administration)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Product, Application, Administration)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, Administration)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • McKesson Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Option Care Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AmerisourceBergen Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CVS Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Walgreens Boots Alliance (USA/UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Linde plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Centene Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • UnitedHealth Group (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anthem, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Humana Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cigna Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Medical (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICU Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Conclusion & Recommendation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦